Ángela Sánchez Osuna

Institutions of which they are part

Postdoctoral researcher
Gene Therapy at Nervous System

Vall Hebron Institut de Recerca

Ángela Sánchez Osuna

Institutions of which they are part

Postdoctoral researcher
Gene Therapy at Nervous System

Vall Hebron Institut de Recerca

Related news

European Partnership Opens a New Era in Rare Disease Research

The European Rare Diseases Research Alliance (ERDERA) kicked off this September, with an estimated budget of 380 million euros and the aim of improving the lives of 30 million rare disease patients in Europe and beyond.

VHIR leads a gene therapy study to stop the progression of neurodegenerative diseases

This gene therapy protects mice against cognitive deficits associated with aging, improves motor function, and delays the onset of diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease.

Vall d'Hebron trains future professionals in the use of gene therapy

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.